G. Paul Amminger

机构：Orygen

发表论文 356 篇 · 总被引 19265 次 · h-index 68

代表论文

• Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis (2024 · Schizophrenia Bulletin · 被引 82)
• Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis (2023 · JAMA Psychiatry · 被引 61)
• Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the UHR 1000+ cohort (2024 · World Psychiatry · 被引 23)
• Transdiagnostic risk identification: A validation study of the Clinical High At Risk Mental State (CHARMS) criteria (2024 · Psychiatry Research · 被引 20)
• Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations (2025 · Schizophrenia · 被引 10)
• Non-psychotic Outcomes in Young People at Ultra-High Risk of Developing a Psychotic Disorder: A Long-Term Follow-up Study (2024 · Schizophrenia Bulletin · 被引 10)